Friedreich's Ataxia
Why in News?
Friedreich's Ataxia (FA) is in the news due to a study from the University of Oklahoma Health Sciences Center, which mapped its historical origins and population patterns, alongside global healthcare debates regarding state funding and reimbursement for its breakthrough treatment, Skyclarys (omaveloxolone).
About
- Definition: It is a rare, inherited, progressive neurodegenerative movement disorder that severely damages the nervous system and the heart.
- Ataxia Meaning: The term "ataxia" refers to a lack of voluntary muscle control, causing severe coordination and balance problems.
The Genetic Cause
- FXN Gene Mutation: The condition is caused by defects in the FXN gene located on chromosome 9, which handles the code for a mitochondrial protein called frataxin.
- Trinucleotide Repeat Expansion: Affected individuals have an abnormal repetition of the GAA DNA sequence (repeating 100 to 1,500 times compared to normal variants of under 30).
- Mitochondrial Dysfunction: The mutation blocks frataxin production, depriving energy-heavy nerve and heart cells of ATP (cellular energy currency) and causing toxic iron to accumulate.
Mode of Inheritance
- Autosomal Recessive: A person must inherit two defective copies of the mutated gene (one from each parent) to manifest the disease.
- Carrier Status: Parents carrying only one mutated gene are called carriers; they remain completely asymptomatic but hold a 25% chance of passing it to their children.
- Consanguineous Factor: The disease is highly prevalent in offspring resulting from consanguineous marriages (marriages between blood relatives like cousins).
Major Symptoms
- Movement Issues: Early symptoms include unsteady posture, frequent falling, awkward movements, and an unstable gait.
- Speech & Sensation: Progression causes slurred speech (dysarthria), difficulty swallowing (dysphagia), and rapid loss of physical sensation in limbs.
- Cardiac Complications: Over time, patients develop hypertrophic cardiomyopathy (heart muscle disease) and arrhythmias, which are the leading causes of premature mortality.
- Skeletal & Metabolic: Manifests as extreme chronic fatigue, curvature of the spine (scoliosis), high foot arches, and diabetes mellitus.
Age of Onset & Progression
- Typical Onset: Symptoms usually surface during childhood or early adolescence, most commonly between 5 and 15 years of age.
- Wheelchair Dependence: Due to its progressive nature, the majority of patients require a wheelchair 10 to 20 years after initial symptoms appear.
- Diagnosis: Identified through targeted genetic testing to count GAA repeats and via clinical MRI evaluations.
- No Absolute Cure: There is currently no permanent cure to reverse the disease.
- Management: Modern management relies heavily on Biogen's Skyclarys to slow down progression, surgical interventions for scoliosis, and symptom-focused rehabilitative therapies.
